United States · FDA National Drug Code directory
ERAXIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0049-2242_febc29a8-fd4f-40bc-9335-b4e2233ea606
- Product NDC
- 0049-2242
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- anidulafungin
- Labeler
- Roerig
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240220
- Source listing expiry
- 20261231
Source-listed ingredients
- ANIDULAFUNGIN — 100 mg/30mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0049-2242-01) / 30 mL in 1 VIAL, SINGLE-DOSE · 0049-2242-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →